INGN
Q4 2026 EPS Estimate
$-0.11
Nov 4, 2026
Revenue Estimate
$92M
FY2029E EPS$0.05
FY2030E EPS$0.17

Analyst Sentiment

Wall St. Consensus
Buy
10 analysts·Moderate coverage
63
Score
6 Buy (60%)3 Hold (30%)1 Sell (10%)
Rating Breakdown
Strong Buy
00%
Buy
660%
Hold
330%
Sell
110%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$26.00
+362.6%
Consensus
$26.00
+362.6%
Bull
$26.00
+362.6%
12-Month Target Range10 analysts
$26.00$26.00$26.00
Current $5.62Consensus
Current Price
$5.62
Upside to Consensus
$20.38

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.68%
EPS
FY2028
Rev+5.76%
EPS
FY2029
Rev+15.22%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$357M$373M$395M$455M$476M
Low$353M$370M$386M$451M$472M
High$359M$376M$404M$458M$480M
EBITDA Avg$-13M$-13M$-14M$-16M$-17M
Low$-13M$-13M$-14M$-16M$-17M
High$-13M$-13M$-14M$-16M$-17M
EBIT Avg$-34M$-36M$-38M$-44M$-46M
Low$-35M$-36M$-39M$-44M$-46M
High$-34M$-36M$-37M$-43M$-45M
Net Income Avg$-21M$-13M$-10M$1M$5M
Low$-21M$-13M$-11M$1M$5M
High$-20M$-13M$-4M$1M$5M
EPS Avg$-0.76$-0.47$-0.27$0.05$0.17
Low$-0.76$-0.47$-0.41$0.05$0.17
High$-0.75$-0.46$-0.13$0.05$0.17
Analysts (Rev / EPS)2 / 12 / 12 / 21 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$92M$84M$87M$97M$98M$89M$92M$104M
Low$92M$84M$87M$97M$98M$89M$92M$103M
High$93M$84M$87M$98M$98M$90M$93M$104M
EBITDA Avg$-3M$-3M$-3M$-3M$-4M$-3M$-3M$-4M
Low$-3M$-3M$-3M$-4M$-4M$-3M$-3M$-4M
High$-3M$-3M$-3M$-3M$-4M$-3M$-3M$-4M
EBIT Avg$-9M$-8M$-8M$-9M$-9M$-9M$-9M$-10M
Low$-9M$-8M$-8M$-9M$-9M$-9M$-9M$-10M
High$-9M$-8M$-8M$-9M$-9M$-9M$-9M$-10M
Net Income Avg$-4M$-5M$-6M$-2M$-2M$-4M$-5M$-922,237
Low$-4M$-5M$-6M$-2M$-2M$-4M$-5M$-926,881
High$-3M$-5M$-6M$-2M$-2M$-4M$-5M$-917,707
EPS Avg$-0.13$-0.18$-0.21$-0.08$-0.07$-0.14$-0.18$-0.03
Low$-0.13$-0.18$-0.21$-0.08$-0.08$-0.14$-0.18$-0.03
High$-0.13$-0.18$-0.21$-0.08$-0.07$-0.14$-0.18$-0.03
Analysts (Rev / EPS)2 / 12 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jul 14, 2023Needham
Declining Sales In Challenged Oxygen Market Weighs On Inogen's Margins, Analyst Downgrades Stock
Target:$26.00
+194.8%from $8.82
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.